HEADER HYDROLASE/HYDROLASE INHIBITOR 26-MAY-94 1TMU
TITLE CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN
TITLE 2 ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN;
COMPND 3 CHAIN: L;
COMPND 4 FRAGMENT: RESIDUES 328-363;
COMPND 5 SYNONYM: COAGULATION FACTOR II;
COMPND 6 EC: 3.4.21.5;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: THROMBIN HEAVY CHAIN;
COMPND 9 CHAIN: H;
COMPND 10 FRAGMENT: RESIDUES 364-622;
COMPND 11 SYNONYM: COAGULATION FACTOR II;
COMPND 12 EC: 3.4.21.5;
COMPND 13 MOL_ID: 3;
COMPND 14 MOLECULE: HIRUDIN VARIANT-2;
COMPND 15 CHAIN: J;
COMPND 16 FRAGMENT: RESIDUES 62-72;
COMPND 17 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 MOL_ID: 2;
SOURCE 6 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 7 ORGANISM_COMMON: HUMAN;
SOURCE 8 ORGANISM_TAXID: 9606;
SOURCE 9 MOL_ID: 3;
SOURCE 10 SYNTHETIC: YES;
SOURCE 11 ORGANISM_SCIENTIFIC: HIRUDO MEDICINALIS;
SOURCE 12 ORGANISM_COMMON: MEDICINAL LEECH;
SOURCE 13 ORGANISM_TAXID: 6421
KEYWDS SERINE PROTEASE, PPACK INHIBITOR, BLOOD COAGULATION, HYDROLASE-
KEYWDS 2 HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.P.PRIESTLE,M.G.GRUETTER
REVDAT 7 23-OCT-24 1TMU 1 HETSYN
REVDAT 6 29-JUL-20 1TMU 1 COMPND REMARK HETNAM LINK
REVDAT 6 2 1 SITE
REVDAT 5 29-NOV-17 1TMU 1 HELIX
REVDAT 4 13-JUL-11 1TMU 1 VERSN
REVDAT 3 24-FEB-09 1TMU 1 VERSN
REVDAT 2 01-APR-03 1TMU 1 JRNL
REVDAT 1 30-SEP-94 1TMU 0
JRNL AUTH J.P.PRIESTLE,J.RAHUEL,H.RINK,M.TONES,M.G.GRUTTER
JRNL TITL CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES
JRNL TITL 2 AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS.
JRNL REF PROTEIN SCI. V. 2 1630 1993
JRNL REFN ISSN 0961-8368
JRNL PMID 8251938
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH E.SKRZYPCZAK-JANKUN,V.E.CARPEROS,K.G.RAVICHANDRAN,A.TULINSKY
REMARK 1 TITL STRUCTURE OF THE HIRUGEN AND HIRULOG COMPLEXES OF
REMARK 1 TITL 2 ALPHA-THROMBIN
REMARK 1 REF J.MOL.BIOL. V. 221 1379 1991
REMARK 1 REFN ISSN 0022-2836
REMARK 1 REFERENCE 2
REMARK 1 AUTH T.J.RYDEL,A.TULINSKY,W.BODE,R.HUBER
REMARK 1 TITL REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX
REMARK 1 REF J.MOL.BIOL. V. 221 583 1991
REMARK 1 REFN ISSN 0022-2836
REMARK 1 REFERENCE 3
REMARK 1 AUTH M.G.GRUETTER,J.P.PRIESTLE,J.RAHUEL,H.GROSSENBACHER,W.BODE,
REMARK 1 AUTH 2 J.HOFSTEENGE,S.R.STONE
REMARK 1 TITL CRYSTAL STRUCTURE OF THE THROMBIN-HIRUDIN COMPLEX: A NOVEL
REMARK 1 TITL 2 MODE OF SERINE PROTEASE INHIBITION
REMARK 1 REF EMBO J. V. 9 2361 1990
REMARK 1 REFN ISSN 0261-4189
REMARK 1 REFERENCE 4
REMARK 1 AUTH W.BODE,I.MAYR,U.BAUMANN,R.HUBER,S.R.STONE,J.HOFSTEENGE
REMARK 1 TITL THE REFINED 1.9 ANGSTROM CRYSTAL STRUCTURE OF HUMAN ALPHA
REMARK 1 TITL 2 THROMBIN: INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE
REMARK 1 TITL 3 AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
REMARK 1 REF EMBO J. V. 8 3467 1989
REMARK 1 REFN ISSN 0261-4189
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : TNT
REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : NULL
REMARK 3
REMARK 3 USING DATA ABOVE SIGMA CUTOFF.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING + TEST SET) : 0.202
REMARK 3 R VALUE (WORKING SET) : NULL
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3
REMARK 3 USING ALL DATA, NO SIGMA CUTOFF.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2400
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 44
REMARK 3 SOLVENT ATOMS : 72
REMARK 3
REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT
REMARK 3 BOND LENGTHS (A) : 0.019 ; NULL ; NULL
REMARK 3 BOND ANGLES (DEGREES) : 3.400 ; NULL ; NULL
REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL
REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL
REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL
REMARK 3
REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 RESTRAINT LIBRARIES.
REMARK 3 STEREOCHEMISTRY : NULL
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1TMU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000176738.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : NULL
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : NULL
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : NULL
REMARK 200 RADIATION SOURCE : NULL
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL
REMARK 200 WAVELENGTH OR RANGE (A) : NULL
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : NULL
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL
REMARK 200 RESOLUTION RANGE HIGH (A) : NULL
REMARK 200 RESOLUTION RANGE LOW (A) : NULL
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : NULL
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 56.93
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X+1/2,Y+1/2,-Z
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 40.45000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.75000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.45000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.75000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5050 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 13200 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, J
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY H 246
REMARK 465 GLU H 247
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS H 81 CD CE NZ
REMARK 470 LYS H 110 CG CD CE NZ
REMARK 470 LYS H 149E CG CD CE NZ
REMARK 470 LYS H 236 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OG SER H 195 O2 0G6 H 1 2.07
REMARK 500 OD2 ASP H 189 O HOH H 292 2.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 GLU L 13 CD GLU L 13 OE2 0.069
REMARK 500 GLU L 14E CD GLU L 14E OE1 0.069
REMARK 500 GLU L 14H CD GLU L 14H OE1 0.084
REMARK 500 GLU H 39 CD GLU H 39 OE1 0.072
REMARK 500 GLU H 80 CD GLU H 80 OE2 0.070
REMARK 500 GLU H 97A CD GLU H 97A OE1 0.070
REMARK 500 GLU H 127 CD GLU H 127 OE1 0.080
REMARK 500 GLU H 164 CD GLU H 164 OE2 0.076
REMARK 500 GLU H 192 CD GLU H 192 OE1 0.068
REMARK 500 GLU J 58 CD GLU J 58 OE2 0.081
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG L 4 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES
REMARK 500 ARG L 4 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES
REMARK 500 PHE L 7 CB - CG - CD1 ANGL. DEV. = 4.5 DEGREES
REMARK 500 SER H 27 CB - CA - C ANGL. DEV. = -16.4 DEGREES
REMARK 500 SER H 36A CB - CA - C ANGL. DEV. = -13.0 DEGREES
REMARK 500 GLU H 39 N - CA - CB ANGL. DEV. = -13.7 DEGREES
REMARK 500 SER H 45 N - CA - CB ANGL. DEV. = -12.6 DEGREES
REMARK 500 ASP H 60E CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES
REMARK 500 PHE H 60H CB - CG - CD2 ANGL. DEV. = 4.2 DEGREES
REMARK 500 LEU H 64 CB - CA - C ANGL. DEV. = -15.7 DEGREES
REMARK 500 ARG H 73 NE - CZ - NH1 ANGL. DEV. = -3.6 DEGREES
REMARK 500 THR H 74 N - CA - CB ANGL. DEV. = -18.3 DEGREES
REMARK 500 ARG H 93 CD - NE - CZ ANGL. DEV. = 11.8 DEGREES
REMARK 500 ASP H 102 CB - CG - OD1 ANGL. DEV. = 6.0 DEGREES
REMARK 500 ASP H 125 CB - CG - OD1 ANGL. DEV. = 6.8 DEGREES
REMARK 500 ASP H 125 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES
REMARK 500 ARG H 137 CD - NE - CZ ANGL. DEV. = 14.3 DEGREES
REMARK 500 ARG H 137 NE - CZ - NH1 ANGL. DEV. = 4.9 DEGREES
REMARK 500 ARG H 137 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES
REMARK 500 ARG H 165 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 ASP H 170 CB - CG - OD1 ANGL. DEV. = 7.8 DEGREES
REMARK 500 ASP H 170 CB - CG - OD2 ANGL. DEV. = -8.3 DEGREES
REMARK 500 ARG H 175 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES
REMARK 500 ARG H 175 NE - CZ - NH2 ANGL. DEV. = 4.2 DEGREES
REMARK 500 ILE H 176 N - CA - CB ANGL. DEV. = -18.5 DEGREES
REMARK 500 ASP H 178 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES
REMARK 500 ASP H 194 CB - CG - OD1 ANGL. DEV. = -5.5 DEGREES
REMARK 500 ARG H 206 CB - CA - C ANGL. DEV. = -12.5 DEGREES
REMARK 500 ARG H 221A CA - CB - CG ANGL. DEV. = -16.4 DEGREES
REMARK 500 ASP H 222 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES
REMARK 500 ASP J 55 CA - CB - CG ANGL. DEV. = 18.5 DEGREES
REMARK 500 ASP J 55 CB - CG - OD1 ANGL. DEV. = 10.2 DEGREES
REMARK 500 ASP J 55 CB - CG - OD2 ANGL. DEV. = -9.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PHE L 7 -76.07 -118.49
REMARK 500 LYS L 9 -4.69 -54.38
REMARK 500 SER H 48 -174.98 177.68
REMARK 500 ASP H 60E 32.54 72.74
REMARK 500 ASN H 60G 77.27 -161.37
REMARK 500 HIS H 71 -51.29 -131.30
REMARK 500 GLU H 97A -54.11 -129.57
REMARK 500 ASP H 189 168.01 179.25
REMARK 500 ASN H 204B 4.05 -150.39
REMARK 500 SER H 214 -55.81 -126.25
REMARK 500 LEU J 64 78.73 -67.94
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS D-PHE-PRO-ARG-
REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO
REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL
REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)METHYL]
REMARK 630 AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-PROLINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0G6 H 1
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: DPN PRO AR7 0QE
REMARK 630 DETAILS: NULL
REMARK 700
REMARK 700 SHEET
REMARK 700 THE SHEET PRESENTED AS *BS1* ON SHEET RECORDS BELOW IS
REMARK 700 ACTUALLY A SIX-STRANDED BETA-BARREL. THIS IS REPRESENTED
REMARK 700 BY A SEVEN-STRANDED SHEET IN WHICH THE FIRST AND LAST
REMARK 700 STRANDS ARE IDENTICAL. THE SHEET PRESENTED AS *BS2* ON
REMARK 700 SHEET RECORDS BELOW IS ACTUALLY A SEVEN-STRANDED BETA-
REMARK 700 BARREL. THIS IS REPRESENTED BY AN EIGHT-STRANDED SHEET IN
REMARK 700 WHICH THE FIRST AND SECOND TO LAST STRANDS ARE IDENTICAL.
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: CAT
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: CATALYTIC TRIAD OF THROMBIN
REMARK 800
REMARK 800 SITE_IDENTIFIER: S1
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: BINDING SUBSITES 1 ON THROMBIN
REMARK 800
REMARK 800 SITE_IDENTIFIER: S2
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: BINDING SUBSITES 2 ON THROMBIN
REMARK 800
REMARK 800 SITE_IDENTIFIER: S3
REMARK 800 EVIDENCE_CODE: AUTHOR
REMARK 800 SITE_DESCRIPTION: BINDING SUBSITES 3 ON THROMBIN
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1TMT RELATED DB: PDB
REMARK 900 UNSPECIFIED
DBREF 1TMU L 1 14 UNP P00734 THRB_HUMAN 333 360
DBREF 1TMU H 16 245 UNP P00734 THRB_HUMAN 364 622
DBREF 1TMU J 55 65 UNP P09945 HIRV2_HIRME 62 72
SEQRES 1 L 28 GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS
SEQRES 2 L 28 SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER
SEQRES 3 L 28 TYR ILE
SEQRES 1 H 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO
SEQRES 2 H 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU
SEQRES 3 H 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU
SEQRES 4 H 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS
SEQRES 5 H 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS
SEQRES 6 H 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE
SEQRES 7 H 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN
SEQRES 8 H 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS
SEQRES 9 H 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO
SEQRES 10 H 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU
SEQRES 11 H 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN
SEQRES 12 H 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN
SEQRES 13 H 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU
SEQRES 14 H 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR
SEQRES 15 H 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY
SEQRES 16 H 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO
SEQRES 17 H 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN
SEQRES 18 H 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP
SEQRES 19 H 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS
SEQRES 20 H 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU
SEQRES 1 J 11 ASP PHE GLU GLU ILE PRO GLU GLU TYS LEU GLN
MODRES 1TMU ASN H 60G ASN GLYCOSYLATION SITE
MODRES 1TMU TYS J 63 TYR O-SULFO-L-TYROSINE
HET TYS J 63 16
HET 0G6 H 1 30
HET NAG H 250 14
HETNAM TYS O-SULFO-L-TYROSINE
HETNAM 0G6 D-PHENYLALANYL-N-[(2S,3S)-6-{[AMINO(IMINIO)
HETNAM 2 0G6 METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L-
HETNAM 3 0G6 PROLINAMIDE
HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE
HETSYN 0G6 PPACK
HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-
HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO-
HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE
FORMUL 3 TYS C9 H11 N O6 S
FORMUL 4 0G6 C21 H34 CL N6 O3 1+
FORMUL 5 NAG C8 H15 N O6
FORMUL 6 HOH *72(H2 O)
HELIX 1 AH1 ARG L 4 SER L 11 1MIXED ALPHA, 3/10 8
HELIX 2 AH2 THR L 14B TYR L 14J 1MIXED ALPHA, 3/10 9
HELIX 3 BH1 ASP H 125 LEU H 130 1 9
HELIX 4 BH2 GLU H 164 SER H 171 1 8
HELIX 5 BH3 LEU H 234 PHE H 245 1 12
HELIX 6 HH1 PRO J 60 LEU J 64 5 5
SHEET 1 BS1 7 TRP H 29 LYS H 36 0
SHEET 2 BS1 7 GLU H 39 ILE H 47 -1 N ALA H 44 O VAL H 31
SHEET 3 BS1 7 ARG H 50 THR H 54 -1 N LEU H 53 O SER H 45
SHEET 4 BS1 7 ILE H 103 LYS H 109 -1 N MET H 106 O VAL H 52
SHEET 5 BS1 7 LYS H 81 HIS H 91 -1 N TYR H 89 O LEU H 105
SHEET 6 BS1 7 ASP H 63 ILE H 68 -1 N VAL H 66 O SER H 83
SHEET 7 BS1 7 TRP H 29 LYS H 36 -1 N PHE H 34 O LEU H 65
SHEET 1 BS2 8 LEU H 155 VAL H 163 0
SHEET 2 BS2 8 ASN H 179 GLY H 184 -1 N GLY H 184 O PRO H 161
SHEET 3 BS2 8 GLY H 226 VAL H 231 -1 N TYR H 228 O PHE H 181
SHEET 4 BS2 8 ASN H 204B TRP H 215 -1 N ILE H 212 O THR H 229
SHEET 5 BS2 8 GLY H 196 SER H 203 -1 N MET H 201 O TYR H 208
SHEET 6 BS2 8 GLY H 133 GLY H 140 -1 N ARG H 137 O VAL H 200
SHEET 7 BS2 8 LEU H 155 VAL H 163 -1 N VAL H 158 O VAL H 138
SHEET 8 BS2 8 SER H 20 ALA H 22 -1 N SER H 20 O VAL H 157
SSBOND 1 CYS L 1 CYS H 122 1555 1555 2.03
SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.01
SSBOND 3 CYS H 168 CYS H 182 1555 1555 2.02
SSBOND 4 CYS H 191 CYS H 220 1555 1555 2.04
LINK C3 0G6 H 1 NE2 HIS H 57 1555 1555 1.37
LINK C2 0G6 H 1 OG SER H 195 1555 1555 1.38
LINK ND2 ASN H 60G C1 NAG H 250 1555 1555 1.32
LINK C GLU J 62 N TYS J 63 1555 1555 1.30
LINK C TYS J 63 N LEU J 64 1555 1555 1.33
CISPEP 1 SER H 36A PRO H 37 0 -5.59
SITE 1 CAT 3 SER H 195 HIS H 57 ASP H 102
SITE 1 S1 10 HIS H 57 ASP H 189 ALA H 190 CYS H 191
SITE 2 S1 10 SER H 195 TRP H 215 GLY H 216 GLY H 219
SITE 3 S1 10 CYS H 220 GLY H 226
SITE 1 S2 5 HIS H 57 TYR H 60A LEU H 99 GLU H 192
SITE 2 S2 5 SER H 214
SITE 1 S3 4 GLU H 97A ASN H 98 LEU H 99 TRP H 215
CRYST1 80.900 107.500 45.900 90.00 90.00 90.00 P 21 21 2 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012361 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009302 0.000000 0.00000
SCALE3 0.000000 0.000000 0.021786 0.00000